Innokas Medical participated in the project where the regulatory framework for NTNU’s new set of reagents were created.
Recent Posts
Three manufacturing sites offer flexible contract manufacturing and agile capacity increasing adjusting to customer-specific needs.
Innokas Medical has launched free webinar series to share ideas and experiences around medical device quality and regulatory matters. In our 8th webinar we will discuss about Clinical Evaluation of...
Medical device regulations include requirements with which both the device and their manufacturer need to comply to enable legal market entry. However, these requirements are often vaque, described...
Innokas Medical will join Lääketietokeskus' online event on March 16th, where the regulatory requirements of medical devices outside the EU will be discussed. Our talented Linda Kellberg (Specialist,...
Together with our cooperation partner Swedish Medtech we would like to discuss about Clinical Evaluation of Medical Device Software. Thus, we've been invited to hold an online event with Swedish...
FlowOx 2.0, developed in co-creation between Norwegian company Otivio AS and Innokas Medical, is a clinically promising, patented and cost-efficient home treatment solution for Peripheral Arterial...
Innokas Medical and our partner Biocodex PhaMe have been invited to BioTreffit & Health Tuesday -event organized by Turku Science Park Oy and Business Finland, to discuss about development of...
The Innovation Voucher, offered by Business Finland, is one funding opportunity for Finnish SMEs who seek for purchasing new knowledge and skills for their business. According to Business Finland,...
